Skip to content
HowShorted

Tabula Rasa HealthCare, Inc. short interest in 2022

In 2022, Tabula Rasa HealthCare, Inc.'s disclosed short interest ran from 9.68% of shares outstanding on 14 Jan 2022 to 4.50% on 30 Dec 2022, a change of -5.18 percentage points. The year's high was 11.99% on 15 Mar 2022 and its low 4.50% on 30 Dec 2022, averaging 7.45% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 18.62 days on 30 Dec 2022. Full history: Tabula Rasa HealthCare, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2019 · 2020 · 2021 · 2022 · 2023

Aggregate net short position time series for Tabula Rasa HealthCare, Inc. in 2022

2022 in figures

Start of year
9.68% (14 Jan 2022)
End of year
4.50% (30 Dec 2022)
Change
-5.18 pp
High
11.99% (15 Mar 2022)
Low
4.50% (30 Dec 2022)
Average
7.45%
Highest days to cover
18.62 (30 Dec 2022)
SEC filings marked
9

Every report in 2022

Tabula Rasa HealthCare, Inc. short interest in 2022
SettlementShort interestDays to coverFilings since previous
14 Jan 20229.68%8.36
31 Jan 20229.22%6.76
15 Feb 202210.10%6.87
28 Feb 202211.24%2.3310-K filed, results (8-K)
15 Mar 202211.99%2.00
31 Mar 20228.21%1.58
14 Apr 20227.45%5.93
29 Apr 20228.75%3.55
13 May 20228.59%3.16results (8-K), 10-Q filed
31 May 20229.74%3.52
15 Jun 20229.13%7.05
30 Jun 20226.30%1.00
15 Jul 20226.20%6.23
29 Jul 20228.39%1.00results (8-K)
15 Aug 20226.72%2.40results (8-K), 10-Q filed
31 Aug 20225.63%6.95
15 Sep 20225.63%11.78
30 Sep 20225.53%10.28
14 Oct 20225.54%18.33
31 Oct 20225.18%17.61
15 Nov 20225.13%15.89results (8-K), 10-Q filed
30 Nov 20225.35%11.73
15 Dec 20224.56%9.69
30 Dec 20224.50%18.62

See also: Tabula Rasa HealthCare, Inc.'s full history · most shorted US stocks of 2022 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.